Cell line · CVCL_B488
Papers40
1 to 20 of 40
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Surface protein profiling reveals depot-specific features of subcutaneous and visceral adipose progenitor cells. | Biochem Biophys Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cblb Gene Editing in T Cells Sustains Expansion and Immunogenic CAR T Tumor Killing Under Chronic Antigenic Stimulation. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Naive CD4+ T cells synthesize a hyaluronan-rich glycocalyx that is diminished following activation. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| E-cadherin expression promotes tumor growth via KLRG1-dependent pathways. | J Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hyperactivation of mTORC1 blocks stem cell fate transitions through TFE3-NuRD association. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Variant-specific interaction of kinectin 1 with the multi-tRNA synthetase complex regulates ER sheet organization. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TET3 protects the Dlk1-Dio3 imprinted locus from DNA hypomethylation during adult NSC reprogramming. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| T cell cholesterol transport links intestinal immune responses to dietary lipid absorption. | Science | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Unraveling the impact of crizotinib to promote megakaryopoiesis for alleviating thrombocytopenia in myelodysplastic neoplasms. | Leukemia | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression. | Cancer Immunol Immunother | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy. | Cell Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Obesity reshapes regulatory T cells in the visceral adipose tissue by disrupting cellular cholesterol homeostasis. | Sci Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Lung Cancer-Intrinsic SOX2 Expression Mediates Resistance to Checkpoint Blockade Therapy by Inducing Treg-Dependent CD8+ T-cell Exclusion. | Cancer Immunol Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation. | Elife | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness. | Cancer Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks. | Immunity | 2024 | Its Methods give the RRID and name the line | PubMed | |
| One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. | Clin Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_B488/papers